Effectiveness of Six Sessions CBT for Adolescents With Emotional Problems in Community Clinics
SMART
Effectiveness of Cognitive Behavioral Short-term Treatment for Adolescents With Emotional Symptom Problems in Community Clinics in Norway. A Randomized Controlled Study
2 other identifiers
interventional
163
1 country
1
Brief Summary
Background: There is need for more effectiveness studies concerning treatment of emotional symptom problems indicating anxiety and depression in adolescents. SMART is the only treatment manual for combined emotional disorders developed in Norwegian. Purpose: To find the best individualized treatment for adolescents with emotional difficulties by: Finding criteria for the selection of appropriate patients for treatment with cognitive-behavior therapy program SMART in an outpatient population (14-18 years). Finding predictors of completion of treatment program SMART. Examining the effects of treatment with the SMART program at 6 months follow-up. Design: A randomized controlled study in six outpatient clinics in the north of Norway. N= 160 referred adolescents (14-18 years) with score above 6 on the Emotional Problems scale of the Strength and Difficulties Questionnaire (SDQ). Two thirds are treated according to the SMART-manual immediately, while the waiting list control group is treated with SMART after six weeks. Hypothesis: The SMART treatment is an effective treatment for emotional symptom problems. Publication: The results sought published internationally and nationally and will be communicated to clinicians.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 26, 2014
CompletedFirst Posted
Study publicly available on registry
May 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedMay 23, 2019
May 1, 2019
4.5 years
May 26, 2014
May 21, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Status of primary emotional disorder based on theDevelopment and Well-Being Assessment (DAWBA) interview schedule with parents and youths
Diagnostic interview
At recruitment, before treatment start and at 6 months follow up
Secondary Outcomes (5)
SDQ Strengths and Difficulties Questionnaire
At recruitment, before treatment start and at 6 months follow up
Anxiety symptom score on the Multi-Dimensional Anxiety Scale for Children (MASC)
At recruitment, before treatment start and at 6 months follow up
Depression symptom status as measured by the self-rating instrument Beck Depression Inventory (BDI-II)
At recruitment, before treatment start and at 6 months follow up
Life functioning as measured by the rating scale C-GAS rated by clinicians
At recruitment, before treatment start and at 6 months follow up
General outcome measured by Clinical Outcomes in Routine Evaluations Outcome Measure (CORE-OM)
At recruitment, before treatment start and at 6 months follow up. The short version (CORE 10) mid-therapy: 3 weeks after starting treatment
Study Arms (2)
Waiting list control group
NO INTERVENTION6 week waiting list
Individual cognitive behavioral therapy with SMART
EXPERIMENTALSMART manual cognitive behavioral therapy individual weekly sessions for 6 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Age 14 to 18 years Referred to Community Mental Health Clinic for Children and Adolescents
- Score above 6 on Emotional symptoms scale on the SDQ Fluent Norwegian language
You may not qualify if:
- Indicators for Pervasive Developmental Disorder (PDD) Acute suicidal symptoms Psycho-active drug treatment start coinciding with start of intervention Symptoms indicating psychotic disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Tromsolead
- The Royal Norwegian Ministry of Healthcollaborator
- Regionsenter for barn og unges psykiske helsecollaborator
Study Sites (1)
University Hospital of North Norway
Tromsø, Norway
Related Publications (2)
Lorentzen V, Fagermo K, Handegard BH, Neumer SP, Skre I. Long-term effectiveness and trajectories of change after treatment with SMART, a transdiagnostic CBT for adolescents with emotional problems. BMC Psychol. 2022 Jul 5;10(1):167. doi: 10.1186/s40359-022-00872-y.
PMID: 35791020DERIVEDLorentzen V, Fagermo K, Handegard BH, Skre I, Neumer SP. A randomized controlled trial of a six-session cognitive behavioral treatment of emotional disorders in adolescents 14-17 years old in child and adolescent mental health services (CAMHS). BMC Psychol. 2020 Mar 14;8(1):25. doi: 10.1186/s40359-020-0393-x.
PMID: 32171328DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ingunn Skre, PhD
UiT Arctic University of Norway
- STUDY CHAIR
Simon-Peter Neumer, Dr philos
Regionsenter for barn og unges psykiske helse, Sør-Øst
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2014
First Posted
May 29, 2014
Study Start
January 1, 2013
Primary Completion
June 30, 2017
Study Completion
March 1, 2018
Last Updated
May 23, 2019
Record last verified: 2019-05